Literature DB >> 9466752

Nosocomial Candida glabrata colonization: an epidemiologic study.

J A Vazquez1, L M Dembry, V Sanchez, M A Vazquez, J D Sobel, C Dmuchowski, M J Zervos.   

Abstract

Candida glabrata has emerged as an important nosocomial pathogen, yet little is known about its epidemiology. We prospectively followed 98 patients admitted to a medical intensive care unit and the bone marrow transplant unit of a university hospital. Samples from environmental surfaces and the hands of hospital personnel were also cultured. Patients with newly acquired C. glabrata strains were compared to controls who were culture negative for C. glabrata. C. glabrata was recovered from multiple sites from 24 patients and three environmental surfaces. Sixteen patients (17%) acquired C. glabrata after admission to the study units. Significant risk factors for the nosocomial acquisition of C. glabrata were prolonged duration of hospitalization in the unit and prior antimicrobial use. Strain delineation by restriction enzyme analysis revealed 28 different strains of C. glabrata; three strain types were common to nine patients. The environmental isolates were of the same strain type and common to five patients (four patients with newly acquired strains). These results suggest the possibility of exogenous nosocomial acquisition of C. glabrata, including the possible acquisition from the hospital environment. Transmission may be by indirect contact since identical strains of C. glabrata were recovered from patients who were geographically and temporally associated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9466752      PMCID: PMC104553     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  38 in total

1.  Comparison of restriction enzyme analysis and pulsed-field gradient gel electrophoresis as typing systems for Candida albicans.

Authors:  J A Vazquez; A Beckley; J D Sobel; M J Zervos
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

2.  Applied molecular genetics: new tools for microbiologists and clinicians.

Authors:  B I Eisenstein; N C Engleberg
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

3.  High-level resistance to gentamicin in Streptococcus faecalis: risk factors and evidence for exogenous acquisition of infection.

Authors:  M J Zervos; S Dembinski; T Mikesell; D R Schaberg
Journal:  J Infect Dis       Date:  1986-06       Impact factor: 5.226

4.  Resistogram method for differentiation of strains of Candida albicans.

Authors:  D W Warnock; D C Speller; J K Day; A J Farrell
Journal:  J Appl Bacteriol       Date:  1979-06

5.  An outbreak of candidiasis in a special care baby unit: the use of a resistogram typing method.

Authors:  M Phelps; G A Ayliffe; J R Babb
Journal:  J Hosp Infect       Date:  1986-01       Impact factor: 3.926

6.  Disseminated Candida glabrata: report of a uniquely severe infection and a literature review.

Authors:  W F Hickey; L H Sommerville; F J Schoen
Journal:  Am J Clin Pathol       Date:  1983-11       Impact factor: 2.493

7.  Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy.

Authors:  R Horn; B Wong; T E Kiehn; D Armstrong
Journal:  Rev Infect Dis       Date:  1985 Sep-Oct

8.  Candidiasis in cancer patients.

Authors:  G P Bodey
Journal:  Am J Med       Date:  1984-10-30       Impact factor: 4.965

9.  Torulopsis glabrata sepsis appearing as necrotizing enterocolitis and endophthalmitis.

Authors:  J E Baley; R M Kliegman; W L Annable; B B Dahms; A A Fanaroff
Journal:  Am J Dis Child       Date:  1984-10

10.  Increased incidence of fungemia caused by Candida krusei.

Authors:  W G Merz; J E Karp; D Schron; R Saral
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

View more
  36 in total

1.  Molecular epidemiology of ceftazidime-resistant gram-negative bacilli on inanimate surfaces and their role in cross-transmission during nonoutbreak periods.

Authors:  E M D'Agata; L Venkataraman; P DeGirolami; M Samore
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

Review 2.  The ins and outs of DNA fingerprinting the infectious fungi.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

3.  Rapid identification of Candida species by confocal Raman microspectroscopy.

Authors:  K Maquelin; L P Choo-Smith; H P Endtz; H A Bruining; G J Puppels
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

4.  Emerging Issues in Nosocomial Fungal Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

5.  Serum voriconazole levels following administration via percutaneous jejunostomy tube.

Authors:  Valérie Martinez; Jean-Luc Le Guillou; Christian Lamer; Melissande Le Jouan; Michel Tod; Françoise Dromer
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

6.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

7.  Efficacy of Ibrexafungerp (SCY-078) against Candida auris in an In Vivo Guinea Pig Cutaneous Infection Model.

Authors:  M Ghannoum; N Isham; D Angulo; K Borroto-Esoda; S Barat; L Long
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

8.  Risk factors for fluconazole-resistant Candida glabrata bloodstream infections.

Authors:  Ingi Lee; Neil O Fishman; Theoklis E Zaoutis; Knashawn H Morales; Mark G Weiner; Marie Synnestvedt; Irving Nachamkin; Ebbing Lautenbach
Journal:  Arch Intern Med       Date:  2009-02-23

Review 9.  Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs.

Authors:  Günter Kampf; Axel Kramer
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

10.  Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location.

Authors:  M A Pfaller; S A Messer; L Boyken; S Tendolkar; R J Hollis; D J Diekema
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.